Access the world's leading financial data and tools

Subscribe for $2
Overview
Profile

Joincare Pharmaceutical Group Industry Co stock

600380.SS
CNE000001816

Price

11.97
Today +/-
+0.03
Today %
+2.20 %
P

Joincare Pharmaceutical Group Industry Co stock price

%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the Joincare Pharmaceutical Group Industry Co stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Joincare Pharmaceutical Group Industry Co stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Joincare Pharmaceutical Group Industry Co stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Joincare Pharmaceutical Group Industry Co's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Joincare Pharmaceutical Group Industry Co Stock Price History

DateJoincare Pharmaceutical Group Industry Co Price
11/7/202411.97 undefined
11/6/202411.71 undefined
11/5/202411.85 undefined
11/4/202411.72 undefined
11/1/202411.40 undefined
10/31/202411.29 undefined
10/30/202411.35 undefined
10/29/202411.26 undefined
10/28/202411.64 undefined
10/25/202411.14 undefined
10/24/202410.82 undefined
10/23/202411.02 undefined
10/22/202410.98 undefined
10/21/202410.88 undefined
10/18/202410.96 undefined
10/17/202410.73 undefined
10/16/202410.89 undefined
10/15/202410.94 undefined
10/14/202411.19 undefined
10/11/202411.12 undefined
10/10/202411.40 undefined

Joincare Pharmaceutical Group Industry Co Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Joincare Pharmaceutical Group Industry Co, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Joincare Pharmaceutical Group Industry Co from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Joincare Pharmaceutical Group Industry Co’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Joincare Pharmaceutical Group Industry Co. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Joincare Pharmaceutical Group Industry Co’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Joincare Pharmaceutical Group Industry Co’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Joincare Pharmaceutical Group Industry Co’s growth potential.

Joincare Pharmaceutical Group Industry Co Revenue, EBIT and net profit per share

DateJoincare Pharmaceutical Group Industry Co RevenueJoincare Pharmaceutical Group Industry Co EBITJoincare Pharmaceutical Group Industry Co Net Income
2026e20.05 B undefined0 undefined1.92 B undefined
2025e18.71 B undefined0 undefined1.69 B undefined
2024e17.16 B undefined0 undefined1.53 B undefined
202316.65 B undefined3.04 B undefined1.44 B undefined
202217.14 B undefined3.16 B undefined1.5 B undefined
202115.9 B undefined2.81 B undefined1.33 B undefined
202013.52 B undefined2.68 B undefined1.12 B undefined
201911.98 B undefined1.96 B undefined894 M undefined
201811.2 B undefined1.5 B undefined699 M undefined
201710.78 B undefined1.53 B undefined2.13 B undefined
20169.72 B undefined1.07 B undefined451 M undefined
20158.64 B undefined1.01 B undefined412 M undefined
20147.42 B undefined812 M undefined354 M undefined
20136.22 B undefined728 M undefined274 M undefined
20125.85 B undefined578 M undefined170 M undefined
20114.79 B undefined581 M undefined262 M undefined
20104.47 B undefined1.09 B undefined740 M undefined
20093.68 B undefined766 M undefined486 M undefined
20082.94 B undefined490 M undefined-27 M undefined
20072.5 B undefined394 M undefined725 M undefined
20062.16 B undefined-78 M undefined-48 M undefined
20052.49 B undefined219 M undefined128 M undefined
20042.35 B undefined252 M undefined97 M undefined

Joincare Pharmaceutical Group Industry Co Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (B)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (B)EBIT (B)EBIT MARGIN (%)NET INCOME (B)NET INCOME GROWTH (%)DIV. ()DIV. GROWTH (%)SHARES (B)DOCUMENTS
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024e2025e2026e
0.680.680.711.752.352.492.162.52.943.684.474.795.856.227.428.649.7210.7811.211.9813.5215.917.1416.6517.1618.7120.05
-0.594.86146.0733.906.10-13.2215.6917.5725.3621.457.1322.086.3219.2616.5012.5010.873.946.9312.8717.617.79-2.893.099.037.19
72.7472.1673.6061.3656.3553.1550.3249.8250.7855.4257.1051.7151.4759.9058.3259.9461.7062.4261.7463.9163.3963.6762.8260.29---
0.490.490.521.081.321.321.091.251.492.042.552.483.013.734.335.1866.736.927.668.5710.1310.7710.04000
0.150.170.150.220.250.22-0.080.390.490.771.090.580.580.730.811.011.071.531.51.962.682.813.163.04000
21.6324.3020.9312.3310.748.80-3.6115.7716.6820.8024.2612.129.8811.7010.9511.6811.0314.2213.3416.3819.8217.6818.4418.26---
0.160.20.170.140.10.13-0.050.73-0.030.490.740.260.170.270.350.410.452.130.70.891.121.331.51.441.531.691.92
-28.85-14.43-18.60-30.7131.96-137.50-1,610.42-103.72-1,900.0052.26-64.59-35.1161.1829.2016.389.47372.95-67.2327.9025.2818.5713.10-3.996.3110.5013.40
---------------------------
---------------------------
1.291.741.741.741.741.741.741.741.741.741.741.721.71.71.71.731.751.71.941.941.961.941.91.91000
---------------------------
Details

Keystats

ⓘ

Revenue and Growth

The Joincare Pharmaceutical Group Industry Co Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Joincare Pharmaceutical Group Industry Co is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (B)RECEIVABLES (B)OTHER REC. (B)INVENTORIES (B)OTHER CURRENT LIAB. (B)CURRENT ASSETS (B)TANGIBLE ASSETS (B)LONG-T. INVEST. (B)LONG-T. REC. (M)INTANGIBLE ASSETS (B)GOODWILL (M)OTHER NON-CURRENT ASSETS (M)NON-CURRENT ASSETS (B)TOTAL ASSETS (B)LIABILITIESCOMMON STOCK (B)ADDITIONAL PAID-IN CAPITAL (B)RETAINED EARNINGS (B)OTHER EQUITY (M)UNREAL. GAINS/LOSSES (M)EQUITY (B)LIABILITIES (M)PROVISIONS (B)OTHER SHORT-TERM LIAB. (B)SHORT-TERM DEBTS (B)LONG-TERM DEBT PORTION (M)SHORT-TERM REC. (B)LONG-T. LIAB. (B)DEFERRED TAXES (M)OTHER LIAB. (M)LONG-T. LIABILITIES (B)DEBT (B)TOTAL CAPITAL (B)
200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023
                                               
0.081.651.211.541.240.930.841.491.070.951.182.161.731.261.572.282.958.998.9810.9612.1411.8914.9716.17
0.120.150.20.50.510.50.370.450.510.550.780.891.091.521.561.721.991.871.8822.452.853.12.69
0.030.020.030.160.20.150.370.230.30.720.460.450.470.560.640.780.911.751.451.511.592.122.062.06
0.080.050.080.260.320.330.370.490.510.510.650.630.780.921.11.311.421.361.411.531.832.082.562.66
0.040.030.030.080.140.150.220.140.10.180.20.520.320.30.270.190.910.382.860.590.40.420.480.29
0.341.91.552.532.412.062.172.82.52.93.274.654.394.565.156.288.1914.3316.5816.5818.4119.3723.1823.87
0.30.340.351.031.241.451.71.811.891.92.462.663.54.264.664.834.714.694.74.875.356.126.466.51
0.070.060.520.60.490.620.370.50.430.350.370.420.70.730.871.111.471.531.882.022.212.833.433.22
000000000000001000002011156.653.343.34
0.030.030.10.20.230.220.260.260.250.250.260.290.340.390.480.480.510.550.590.690.871.241.231.17
000000499580615615614614614614614614614614614614614614.47614.47636.34
0015048507074140138142192211192211492580503606650712868.75818.32946.99
0.40.420.981.892.012.332.93.223.333.243.844.175.366.196.947.527.887.888.418.859.7511.7412.5612.48
0.742.332.524.424.414.395.076.025.826.157.118.819.7510.7512.0813.816.0722.2124.9925.4428.1631.135.7436.36
                                               
0.20.270.410.610.610.610.610.611.11.11.321.291.551.551.551.591.591.571.941.941.951.911.931.87
01.641.511.311.311.311.331.321.31.291.050.780.440.440.440.640.950.932.392.42.532.272.341.6
0.030.070.240.240.220.280.260.990.410.771.511.771.942.152.442.72.994.875.295.96.757.869.1910.3
00000-3-16-24-36-36-40-46-47-49-71-43-2654291171165.39-12.550.98
00-5-33-77-81000000000000000017.25-13.23
0.231.982.152.132.062.122.192.92.783.123.843.793.884.084.354.885.57.439.6510.3611.3512.0413.4713.76
323335184208171198298243268332343412549663669618524634632833871.55943.91894.29
0.040.020.20.270.260.270.260.280.320.40.560.720.170.240.120.140.290.340.40.460.582.30.80.56
0.060.090.020.10.060.060.050.090.110.130.170.570.891.071.231.982.273.472.642.863.181.994.194.14
0.340.070.080.760.790.751.190.991.030.490.250.311.260.931.641.881.391.63.272.93.24.13.763.55
2511001872411050302617320012400203999699519991.5863.08718.56
0.50.220.341.321.321.331.71.711.711.331.622.012.833.675.074.786.937.647.377.89.359.759.86
0.010.120.030.030.0900.110.150.20.360.121.251.241.581.671.191.691.20.500.370.853.253.14
000000115245335515233285113182202208.53237.19260.03
033443230393845525695119138184214235382440499546511.54468.54460.18
0.010.120.030.070.120.030.160.240.240.410.171.351.371.731.871.421.961.661.050.681.121.573.963.86
0.510.350.371.381.441.371.861.951.961.741.793.354.164.725.546.496.748.598.698.058.9210.9213.7213.72
0.742.332.523.513.53.484.054.844.744.865.637.148.048.819.911.3712.2316.0318.3418.4120.2722.9727.1827.47
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Joincare Pharmaceutical Group Industry Co provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Joincare Pharmaceutical Group Industry Co's financial health and stability.

Assets

Joincare Pharmaceutical Group Industry Co's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Joincare Pharmaceutical Group Industry Co must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Joincare Pharmaceutical Group Industry Co after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Joincare Pharmaceutical Group Industry Co's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)DEPRECIATION (M)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (M)PAID INTEREST (M)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (B)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (B)CASH FLOW FROM OTHER INVESTING ACTIVITIES (B)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (B)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (B)CASH FLOW FROM OTHER FINANCING ACTIVITIES (B)TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (B)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
2001200220032004200520062007200820092010201120122013201420152016201720182019202020212022
0000000000000000000000
0000000000000000000000
0000000000000000000000
-262-287-630-665-512-500-442-552-713-856-1,156-2,111-2,693-3,285-3,734-4,317-4,808-5,090-5,589-5,699-7,691-7,488
0000000000000000000000
0000000000000000000000
-64-104-261-323-308-255-320-370-485-474-606-713-788-936-1,029-1,182-1,490-1,997-1,281-1,286-1,510-1,420
0.220.240.170.240.360.270.430.460.611.110.650.730.640.981.261.641.871.832.313.032.563.98
-69-92-110-219-367-490-246-217-306-584-440-863-983-817-594-500-480-655-703-830-1,521-1,147
-0.7-0.63-0-0.12-0.29-0.44-0.360.030.08-0.61-0.66-1.15-0.88-1.06-0.8-1.734.72-2.911.31-0.5-1.96-2.25
-0.63-0.540.110.10.080.05-0.120.250.39-0.02-0.22-0.280.1-0.24-0.21-1.235.2-2.252.010.33-0.44-1.1
0000000000000000000000
-0.17-0.030.31-0.1-0.060.49-0.070.07-0.35-0.21.380.190.040.680.15-0.30.230.61-1.04-0.190.941.62
0000000000000000000000
1.4-0.170.1-0.27-0.20.33-0.15-0.19-0.69-0.281.04-0.04-0.170.380.220.64-0.341.4-2.06-1.24-0.970.57
1.71-0.05-0000-0.01-0.01-0.13-0.02-0.270.010.04-00.41.27-0.191.24-0.64-0.69-1.53-0.67
-142-93-210-168-133-160-76-247-209-59-60-242-252-296-324-319-368-446-375-360-382-389
1.480.061.331.091.061.181.11.671.82.653.443.13.75.56.727.7414.359.3110.7611.1911.3415.37
154.214461.621.8-4.6-217.7182.7237.3298.8520.8210.3-129.1-348.3162.5670.31,144.61,389.71,170.51,609.22,194.61,041.672,829.87
0000000000000000000000

Joincare Pharmaceutical Group Industry Co stock margins

The Joincare Pharmaceutical Group Industry Co margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Joincare Pharmaceutical Group Industry Co. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Joincare Pharmaceutical Group Industry Co.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Joincare Pharmaceutical Group Industry Co's sales revenue. A higher gross margin percentage indicates that the Joincare Pharmaceutical Group Industry Co retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Joincare Pharmaceutical Group Industry Co's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Joincare Pharmaceutical Group Industry Co's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Joincare Pharmaceutical Group Industry Co's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Joincare Pharmaceutical Group Industry Co. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Joincare Pharmaceutical Group Industry Co's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Joincare Pharmaceutical Group Industry Co Margin History

Joincare Pharmaceutical Group Industry Co Gross marginJoincare Pharmaceutical Group Industry Co Profit marginJoincare Pharmaceutical Group Industry Co EBIT marginJoincare Pharmaceutical Group Industry Co Profit margin
2026e60.29 %0 %9.58 %
2025e60.29 %0 %9.06 %
2024e60.29 %0 %8.94 %
202360.29 %18.27 %8.67 %
202262.82 %18.45 %8.77 %
202163.67 %17.69 %8.35 %
202063.39 %19.82 %8.28 %
201963.91 %16.38 %7.46 %
201861.74 %13.34 %6.24 %
201762.42 %14.22 %19.79 %
201661.7 %11.03 %4.64 %
201559.94 %11.68 %4.77 %
201458.32 %10.95 %4.77 %
201359.9 %11.7 %4.41 %
201251.47 %9.88 %2.91 %
201151.71 %12.12 %5.47 %
201057.1 %24.26 %16.54 %
200955.42 %20.8 %13.2 %
200850.78 %16.68 %-0.92 %
200749.82 %15.77 %29.01 %
200650.32 %-3.61 %-2.22 %
200553.15 %8.8 %5.14 %
200456.35 %10.74 %4.13 %

Joincare Pharmaceutical Group Industry Co Stock Sales Revenue, EBIT, Earnings per Share

The Joincare Pharmaceutical Group Industry Co earnings per share therefore indicates how much revenue Joincare Pharmaceutical Group Industry Co has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Joincare Pharmaceutical Group Industry Co earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Joincare Pharmaceutical Group Industry Co's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Joincare Pharmaceutical Group Industry Co’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Joincare Pharmaceutical Group Industry Co's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Joincare Pharmaceutical Group Industry Co Revenue, EBIT and net profit per share

DateJoincare Pharmaceutical Group Industry Co Sales per ShareJoincare Pharmaceutical Group Industry Co EBIT per shareJoincare Pharmaceutical Group Industry Co Earnings per Share
2026e10.7 undefined0 undefined1.03 undefined
2025e9.98 undefined0 undefined0.9 undefined
2024e9.16 undefined0 undefined0.82 undefined
20238.73 undefined1.59 undefined0.76 undefined
20229.04 undefined1.67 undefined0.79 undefined
20218.21 undefined1.45 undefined0.69 undefined
20206.91 undefined1.37 undefined0.57 undefined
20196.18 undefined1.01 undefined0.46 undefined
20185.78 undefined0.77 undefined0.36 undefined
20176.33 undefined0.9 undefined1.25 undefined
20165.56 undefined0.61 undefined0.26 undefined
20155 undefined0.58 undefined0.24 undefined
20144.35 undefined0.48 undefined0.21 undefined
20133.65 undefined0.43 undefined0.16 undefined
20123.43 undefined0.34 undefined0.1 undefined
20112.79 undefined0.34 undefined0.15 undefined
20102.57 undefined0.62 undefined0.42 undefined
20092.11 undefined0.44 undefined0.28 undefined
20081.69 undefined0.28 undefined-0.02 undefined
20071.43 undefined0.23 undefined0.42 undefined
20061.24 undefined-0.04 undefined-0.03 undefined
20051.43 undefined0.13 undefined0.07 undefined
20041.35 undefined0.14 undefined0.06 undefined

Joincare Pharmaceutical Group Industry Co business model

Joincare Pharmaceutical Group Industry Co is one of the most popular companies on Eulerpool.com.

Joincare Pharmaceutical Group Industry Co Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Joincare Pharmaceutical Group Industry Co historical P/E ratio, EBIT multiple, and P/S ratio

Joincare Pharmaceutical Group Industry Co shares outstanding

The number of shares was Joincare Pharmaceutical Group Industry Co in 2023 — This indicates how many shares 1.907 B is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Joincare Pharmaceutical Group Industry Co earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Joincare Pharmaceutical Group Industry Co's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Joincare Pharmaceutical Group Industry Co’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Joincare Pharmaceutical Group Industry Co's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Joincare Pharmaceutical Group Industry Co stock splits

In Joincare Pharmaceutical Group Industry Co's history, there have been no stock splits.

Joincare Pharmaceutical Group Industry Co dividend history and estimates

In 2023, Joincare Pharmaceutical Group Industry Co paid a dividend amounting to 0.18 CNY. Dividend means that Joincare Pharmaceutical Group Industry Co distributes a portion of its profits to its owners.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Details

Dividend

ⓘ

Dividend Overview

The dividend per year chart for Joincare Pharmaceutical Group Industry Co provides a comprehensive view of the annual dividends distributed to shareholders. Analyze the trend to understand the consistency and growth in dividend payouts over the years.

Interpretation and Use

A consistent or increasing trend in dividends can indicate the company's profitability and financial health. Investors can use this data to identify Joincare Pharmaceutical Group Industry Co’s potential for long-term investment and income generation through dividends.

Investment Strategy

Incorporate the dividend data in evaluating Joincare Pharmaceutical Group Industry Co's overall performance. A thorough analysis, considering other financial aspects, will help in making informed investment decisions for optimal capital growth and income generation.

Joincare Pharmaceutical Group Industry Co Dividend History

DateJoincare Pharmaceutical Group Industry Co Dividend
2026e0.2 undefined
2025e0.2 undefined
2024e0.2 undefined
20230.18 undefined
20220.15 undefined
20210.15 undefined
20200.16 undefined
20190.16 undefined
20180.16 undefined
20170.15 undefined
20160.09 undefined
20150.09 undefined
20140.04 undefined
20130.04 undefined
20090.08 undefined
20080.04 undefined
20060.06 undefined
20050.04 undefined
20040.07 undefined

Joincare Pharmaceutical Group Industry Co dividend payout ratio

In 2023, Joincare Pharmaceutical Group Industry Co had a payout ratio of 22.96%. The payout ratio indicates the percentage of the company's profits that Joincare Pharmaceutical Group Industry Co distributes as dividends.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Payout ratio
Details

Payout ratio

ⓘ

What is Yearly Payout Ratio?

The yearly payout ratio for Joincare Pharmaceutical Group Industry Co represents the proportion of earnings paid out as dividends to shareholders. It is an indicator of the company's financial health and stability, illustrating how much profit is being returned to investors versus being reinvested back into the company.

How to Interpret the Data

A lower payout ratio for Joincare Pharmaceutical Group Industry Co could mean that the company is reinvesting more into its growth, whereas a higher ratio indicates more earnings are being distributed as dividends. Investors seeking regular income might prefer companies with a higher payout ratio, while those looking for growth may opt for companies with a lower ratio.

Using the Data for Investments

Evaluate Joincare Pharmaceutical Group Industry Co's payout ratio in conjunction with other financial metrics and performance indicators. A sustainable payout ratio, coupled with strong financial health, can indicate a reliable dividend payout. However, a very high ratio might suggest the company is not sufficiently reinvesting in its future growth.

Joincare Pharmaceutical Group Industry Co Payout Ratio History

DateJoincare Pharmaceutical Group Industry Co Payout ratio
2026e21.75 %
2025e21.05 %
2024e21.26 %
202322.96 %
202218.93 %
202121.87 %
202028.07 %
201934.78 %
201845.37 %
201711.62 %
201634.9 %
201537.81 %
201417.28 %
201322.69 %
201222.96 %
201122.96 %
201022.96 %
200929.75 %
2008-193 %
200722.96 %
2006-205.67 %
200560.57 %
2004122.17 %

The World’s Best Investors Are On Eulerpool

Unfortunately, there are currently no price targets and forecasts available for Joincare Pharmaceutical Group Industry Co.

Joincare Pharmaceutical Group Industry Co latest earnings and earnings surprises

DateEPS EstimateEPS ActualQuarterly report
9/30/20110.1 0.04  (-62.59 %)2011 Q3
6/30/20110.16 0.05  (-71.84 %)2011 Q2
12/31/20100.08 0.1  (15.04 %)2010 Q4
9/30/20100.08 0.12  (50.46 %)2010 Q3
9/30/20090.05 0.07  (52.33 %)2009 Q3
6/30/20090.03 0.07  (131.36 %)2009 Q2
3/31/20090.05 0.05  (-1.07 %)2009 Q1
1

Eulerpool ESG Scorecard© for the Joincare Pharmaceutical Group Industry Co stock

Eulerpool World ESG Rating (EESG©)

95/ 100

🌱 Environment

99

👫 Social

99

🏛️ Governance

86

Environment

Scope 1 - Direct Emissions
162,677
Scope 2 - Indirect emissions from purchased energy
870,323.9
Scope 3 - Indirect emissions within the value chain
Total CO₂ emissions
1,033,000.9
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather
Pesticides
Palm Oil
Tobacco
Genetically modified organisms
Climate concept
Sustainable forestry
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency

Social

Percentage of female employees45.785
Percentage of women in management
Percentage of Asian employees
Share of Asian management
Percentage of Hispanic/Latino employees
Hispano/Latino Management share
Percentage of Black employees
Black Management Share
Percentage of white employees
White Management Share
Adult content
Alcohol
Weapons
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept
Occupational health and safety
Catholic

Governance (Corporate Governance)

Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Joincare Pharmaceutical Group Industry Co shareholders

%
Name
Stocks
Change
Date
47.78858 % Shenzhen Baiyeyuan Investment Co., Ltd.895,653,65306/30/2024
1.91707 % Might Seasons Limited35,929,69906/30/2024
1.64554 % Perseverance Asset Management30,840,648-2,997,8486/30/2024
0.98169 % Fullgoal Fund Management Co., Ltd.18,398,7455,810,4036/30/2024
0.69955 % China Southern Asset Management Co. Ltd.13,110,9142,757,5006/30/2024
0.68452 % Hua Life Insurance Co., LTD.12,829,218100,0006/30/2024
0.62147 % Abu Dhabi Investment Authority11,647,653300,0006/30/2024
0.57776 % CPIC Fund Management Co., Ltd.10,828,36296,6006/30/2024
0.49997 % Joincare Pharmaceutical Group Industry Co., Ltd. - 3rd Phase ESOP9,370,40006/30/2024
0.49722 % GF Fund Management Co., Ltd.9,318,881164,2006/30/2024
1
2
3
4
5
...
10

Joincare Pharmaceutical Group Industry Co Executives and Management Board

Mr. Xiong Yu(62)
Joincare Pharmaceutical Group Industry Co President, Director (since 2016)
Compensation 3.6 M
Ms. Guangxia Liu(54)
Joincare Pharmaceutical Group Industry Co Vice Chairman of the Board
Compensation 3.48 M
Mr. Baoguo Zhu(61)
Joincare Pharmaceutical Group Industry Co Chairman of the Board (since 1992)
Compensation 3.34 M
Mr. Qingfeng Qiu(52)
Joincare Pharmaceutical Group Industry Co Finance Director, Vice President, Director
Compensation 2.25 M
Mr. Nanqi Lin(41)
Joincare Pharmaceutical Group Industry Co Vice President, Director
Compensation 2.25 M
1
2
3

Joincare Pharmaceutical Group Industry Co Supply Chain

NameRelationshipTwo-week correlationOne-month correlationThree-Month CorrelationSix-Month CorrelationOne Year CorrelationTwo-Year Correlation
Truking Technology A Stock
Truking Technology A
SupplierCustomer0,510,690,730,740,07-0,51
Livzon Pharmaceutical H Stock
Livzon Pharmaceutical H
SupplierCustomer0,18-0,180,830,750,840,77
1

Most common questions regarding Joincare Pharmaceutical Group Industry Co

What is the P/E ratio of Joincare Pharmaceutical Group Industry Co 2024?

The Joincare Pharmaceutical Group Industry Co P/E ratio is 14.89.

What is the P/S ratio of Joincare Pharmaceutical Group Industry Co 2024?

The Joincare Pharmaceutical Group Industry Co P/S ratio is 1.33.

What is the Quality Investing of Joincare Pharmaceutical Group Industry Co?

The Quality Investing for Joincare Pharmaceutical Group Industry Co is 7/10.

What is the revenue of Joincare Pharmaceutical Group Industry Co 2024?

The expected Joincare Pharmaceutical Group Industry Co revenue is 17.16 B CNY.

How high is the profit of Joincare Pharmaceutical Group Industry Co 2024?

The expected Joincare Pharmaceutical Group Industry Co profit is 1.53 B CNY.

What is the business model of Joincare Pharmaceutical Group Industry Co

No history available for Joincare Pharmaceutical Group Industry Co.

What is the Joincare Pharmaceutical Group Industry Co dividend?

Joincare Pharmaceutical Group Industry Co pays a dividend of 0.15 CNY distributed over payouts per year.

How often does Joincare Pharmaceutical Group Industry Co pay dividends?

The dividend cannot currently be calculated for Joincare Pharmaceutical Group Industry Co or the company does not pay out a dividend.

What is the Joincare Pharmaceutical Group Industry Co ISIN?

The ISIN of Joincare Pharmaceutical Group Industry Co is CNE000001816.

What is the Joincare Pharmaceutical Group Industry Co ticker?

The ticker of Joincare Pharmaceutical Group Industry Co is 600380.SS.

How much dividend does Joincare Pharmaceutical Group Industry Co pay?

Over the past 12 months, Joincare Pharmaceutical Group Industry Co paid a dividend of 0.18 CNY . This corresponds to a dividend yield of about 1.5 %. For the coming 12 months, Joincare Pharmaceutical Group Industry Co is expected to pay a dividend of 0.2 CNY.

What is the dividend yield of Joincare Pharmaceutical Group Industry Co?

The current dividend yield of Joincare Pharmaceutical Group Industry Co is 1.5 %.

When does Joincare Pharmaceutical Group Industry Co pay dividends?

Joincare Pharmaceutical Group Industry Co pays a quarterly dividend. This is distributed in the months of July, July, August, August.

How secure is the dividend of Joincare Pharmaceutical Group Industry Co?

Joincare Pharmaceutical Group Industry Co paid dividends every year for the past 14 years.

What is the dividend of Joincare Pharmaceutical Group Industry Co?

For the upcoming 12 months, dividends amounting to 0.2 CNY are expected. This corresponds to a dividend yield of 1.64 %.

In which sector is Joincare Pharmaceutical Group Industry Co located?

Joincare Pharmaceutical Group Industry Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Joincare Pharmaceutical Group Industry Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Joincare Pharmaceutical Group Industry Co from 7/18/2024 amounting to 0.18 CNY, you needed to have the stock in your portfolio before the ex-date on 7/18/2024.

When did Joincare Pharmaceutical Group Industry Co pay the last dividend?

The last dividend was paid out on 7/18/2024.

What was the dividend of Joincare Pharmaceutical Group Industry Co in the year 2023?

In the year 2023, Joincare Pharmaceutical Group Industry Co distributed 0.15 CNY as dividends.

In which currency does Joincare Pharmaceutical Group Industry Co pay out the dividend?

The dividends of Joincare Pharmaceutical Group Industry Co are distributed in CNY.

All fundamentals about Joincare Pharmaceutical Group Industry Co

Our stock analysis for Joincare Pharmaceutical Group Industry Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Joincare Pharmaceutical Group Industry Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.